[{"address1": "201 Brookline Avenue", "address2": "Suite 901", "city": "Boston", "state": "MA", "zip": "02215", "country": "United States", "phone": "857 320 4900", "website": "https://www.tangotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase 11 loss-of-function mutations for treating lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barbara L. Weber M.D.", "age": 67, "title": "President, CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 1125489, "exercisedValue": 0, "unexercisedValue": 657452}, {"maxAge": 1, "name": "Ms. Daniella  Beckman CPA", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 717616, "exercisedValue": 0, "unexercisedValue": 337565}, {"maxAge": 1, "name": "Mr. Douglas J. Barry Esq., J.D.", "age": 54, "title": "Chief Legal Officer, Chief Compliance Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 674222, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adam S. Crystal M.D., Ph.D.", "age": 47, "title": "President of Research & Development", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 882167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Alan  Ashworth FRS, Ph.D.", "age": 63, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William G. Kaelin Jr., M.D.", "age": 66, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Antoni  Ribas M.D., Ph.D.", "age": 57, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Palmieri Ph.D.", "title": "Head of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jannik N. Andersen Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth Pingpank Hickin", "title": "VP of IR & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.92, "open": 6.99, "dayLow": 6.761, "dayHigh": 7.01, "regularMarketPreviousClose": 6.92, "regularMarketOpen": 6.99, "regularMarketDayLow": 6.761, "regularMarketDayHigh": 7.01, "payoutRatio": 0.0, "beta": 1.642, "forwardPE": -4.767606, "volume": 993556, "regularMarketVolume": 993556, "averageVolume": 3273200, "averageVolume10days": 1563770, "averageDailyVolume10Day": 1563770, "bid": 6.74, "ask": 6.81, "bidSize": 11, "askSize": 7, "marketCap": 753230208, "fiftyTwoWeekLow": 1.03, "fiftyTwoWeekHigh": 12.015, "priceToSalesTrailing12Months": 31.002232, "fiftyDayAverage": 5.8394, "twoHundredDayAverage": 3.39355, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 607454848, "profitMargins": 0.0, "floatShares": 42473599, "sharesOutstanding": 111260000, "sharesShort": 22475890, "sharesShortPriorMonth": 21193333, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.202, "heldPercentInsiders": 0.12262999, "heldPercentInstitutions": 1.11598, "shortRatio": 12.9, "shortPercentOfFloat": 0.24239999, "impliedSharesOutstanding": 111260000, "bookValue": 1.217, "priceToBook": 5.5628595, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -145566000, "trailingEps": -1.32, "forwardEps": -1.42, "enterpriseToRevenue": 25.002, "enterpriseToEbitda": -3.924, "52WeekChange": -0.36610484, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 6.77, "targetHighPrice": 13.0, "targetLowPrice": 8.0, "targetMeanPrice": 10.85714, "targetMedianPrice": 10.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 180784992, "totalCashPerShare": 1.625, "ebitda": -154796000, "totalDebt": 35008000, "quickRatio": 4.517, "currentRatio": 4.75, "totalRevenue": 24296000, "debtToEquity": 25.941, "revenuePerShare": 0.221, "returnOnAssets": -0.31744, "returnOnEquity": -0.76088, "grossProfits": -112152000, "freeCashflow": -75292128, "operatingCashflow": -148252992, "revenueGrowth": -0.84, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -12.87865, "financialCurrency": "USD", "symbol": "TNGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1599139800000, "postMarketChangePercent": 0.0, "postMarketPrice": 6.77, "postMarketChange": 0.0, "regularMarketChange": -0.15, "regularMarketDayRange": "6.761 - 7.01", "shortName": "Tango Therapeutics, Inc.", "longName": "Tango Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1755291590, "regularMarketTime": 1755288000, "exchange": "NGM", "messageBoardId": "finmb_424111353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "regularMarketChangePercent": -2.16763, "regularMarketPrice": 6.77, "esgPopulated": false, "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 3273200, "fiftyTwoWeekLowChange": 5.74, "fiftyTwoWeekLowChangePercent": 5.5728154, "fiftyTwoWeekRange": "1.03 - 12.015", "fiftyTwoWeekHighChange": -5.2450004, "fiftyTwoWeekHighChangePercent": -0.43653768, "fiftyTwoWeekChangePercent": -36.610485, "earningsTimestamp": 1754397000, "earningsTimestampStart": 1762345800, "earningsTimestampEnd": 1762345800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.32, "epsForward": -1.42, "epsCurrentYear": -1.08588, "priceEpsCurrentYear": -6.2345743, "fiftyDayAverageChange": 0.93060017, "fiftyDayAverageChangePercent": 0.15936573, "twoHundredDayAverageChange": 3.37645, "twoHundredDayAverageChangePercent": 0.9949611, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Tango Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]